Silicon Laboratories Current Valuation
| SLAB Stock | USD 217.45 -0.19 -0.09% |
Silicon Laboratories trades at an elevated earnings multiple, reflecting the current earnings and balance-sheet profile. Silicon Laboratories trades at 6.5x book value. That implies a trailing P/E of roughly 260.36. As of December 31, 2025, Enterprise Value Multiple is broadly unchanged at -209.67x, while Enterprise Value remains stable at $1.58 billion. Key valuation fundamentals for Silicon Laboratories' include:
Below Model Estimate
Today
The intrinsic value estimate for Silicon Laboratories is based on a 3 months horizon. Negative profit margins (-6.13%) signal ongoing profitability risk influencing market valuation. Extending the time horizon generally improves valuation stability.
Silicon Laboratories' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account all liquid assets, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enterprise Value | = | Market Cap + Debt | - | Cash |
Current Silicon Laboratories Current Valuation | 6.72 B |
The role of Current Valuation in Silicon Laboratories' valuation is to link financial data to market pricing. A gap between estimated value and market price can hint at mispricing, though other factors matter too. Sector-level factors can push whole industries to trade above or below their past norms. Silicon Laboratories currently trades at a P/E of 260.36, which provides additional valuation context. This valuation framework is meant to add to, not replace, other forms of investment analysis. A price-to-book ratio of 6.50 helps frame the market's assessment of Silicon Laboratories' asset base.
Current Valuation Driver Correlations
The correlation matrix maps how Current Valuation co-moves with Silicon Laboratories' other financial accounts across reporting periods. Positive correlations suggest shared drivers; negative correlations may reflect natural offsets within Silicon Laboratories' financial structure.
Click cells to compare fundamentals
| Competition |
Silicon Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income | $208,950 |
Fundamental Drivers Relationships
Enterprise Value stood at 1.57 billion as of December 31, 2025. Related reported indicator: Enterprise Value Multiple at 25.33 as of December 31, 2025.
Current Valuation Peer Comparison
Peer comparison on Current Valuation is one of the most widely used methods for evaluating Silicon Laboratories relative to competitors. Comparing Silicon Laboratories' Current Valuation against peers surfaces securities trading below their model-implied intrinsic value estimate in the group.Silicon Laboratories is currently under evaluation in current valuation among leading competitors.
Important Fundamentals
| Return On Equity TTM | -0.0465 | |||
| Return On Asset TTM | -0.0278 | |||
| Profit Margin TTM | -0.0613 | |||
| Operating Margin TTM | -0.08 | |||
| Current Valuation | 6.72 B | |||
| Shares Outstanding | 32.98 M | |||
| Shares Owned By Insiders | 1.69 % | |||
| Shares Owned By Institutions | 98.31 % | |||
| Number Of Shares Shorted | 1.51 M | |||
| Price To Earnings TTM | 260.36 X | |||
| Price To Book TTM | 6.50 X | |||
| Price To Sales TTM | 8.74 X | |||
| Revenue TTM | 784.76 M | |||
| Gross Profit TTM | 486.2 M | |||
| EBITDA TTM | -18.85 M | |||
| Net Income TTM | -64.91 M | |||
| Cash And Equivalents TTM | 364.22 M | |||
| Cash Per Share TTM | 41.35 X | |||
| Total Debt TTM | 174.9 M | |||
| Debt To Equity TTM | 0.34 % | |||
| Current Ratio TTM | 7.90 X | |||
| Book Value Per Share TTM | 33.21 X | |||
| Cash Flow From Operations TTM | 95.71 M | |||
| Short Ratio TTM | 4.11 X | |||
| Earnings Per Share | -1.52 X | |||
| Price To Earnings To Growth | 3.12 X | |||
| Target Price | 222.86 | |||
| Number Of Employees | 1.93 K | |||
| Trailing Beta | 1.4 | |||
| Market Capitalization TTM | 7.17 B | |||
| Total Asset TTM | 1.27 B | |||
| Retained Earnings TTM | 936.81 M | |||
| Working Capital TTM | 530.23 M | |||
| Current Asset TTM | 490.85 M | |||
| Current Liabilities TTM | 139.69 M | |||
| Net Asset | 1.27 B |
Financial Metrics, Fundamentals & Methodology
A financial review of Silicon Laboratories starts with revenue scale, margin durability, and liquidity flexibility. The company is currently operating at a loss. Overall market capitalization tier is mid-cap. Latest reported fundamentals for Silicon Laboratories include revenue of 784.76 million, EPS loss of 1.52, negative operating margin of 8.0%, current ratio of 7.9 as of the latest reporting period.
Silicon Laboratories metrics draw on periodic company reporting and market reference feeds, standardized for cross-period comparison. Analyst inputs may be included when coverage is available. Reported income, balance-sheet, and cash-flow fields adhere to GAAP or IFRS presentation rules.
Editorial review and methodology oversight provided by: Ellen Johnson, Member of Macroaxis Editorial Board